 |
answer text |
<p>Following my Rt. hon. Friend the Secretary of State for Health and Social Care’s
announcement on 30 January that the Pre-Exposure Prophylaxis (PrEP) Impact Trial would
be expanded to 26,000 people, NHS England has committed to fund the PrEP drug and
research costs of these additional places, in line with current arrangements.</p><p>Local
authority and clinic participation in the trial is on a voluntary basis. Participation
costs of local authorities are met from existing resource allocations.</p><p>The 36
month PrEP Impact Trial is scheduled to continue until autumn 2020. Work is underway
to prepare for a seamless transition from the PrEP trial to future commissioning arrangements,
which includes consideration of funding options.</p>
|
 |
